Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendiceal Neoplasms | 1 | 2023 | 251 | 0.180 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2023 | 443 | 0.170 |
Why?
|
| Cancer Care Facilities | 1 | 2022 | 908 | 0.140 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 511 | 0.130 |
Why?
|
| Radiation Injuries | 1 | 2001 | 1472 | 0.110 |
Why?
|
| Peritoneal Neoplasms | 1 | 2020 | 858 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 135 | 0.110 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 126 | 0.100 |
Why?
|
| Memory | 1 | 2013 | 445 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2023 | 7981 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 2322 | 0.070 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2008 | 123 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 3705 | 0.070 |
Why?
|
| Observer Variation | 2 | 2022 | 720 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2013 | 1325 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 2008 | 313 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2008 | 564 | 0.060 |
Why?
|
| Pyrroles | 1 | 2008 | 592 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 532 | 0.060 |
Why?
|
| Indoles | 1 | 2008 | 1034 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2008 | 1379 | 0.050 |
Why?
|
| Leucovorin | 1 | 2023 | 345 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2008 | 1553 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 453 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 178 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2001 | 751 | 0.040 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2020 | 182 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 285 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2023 | 1989 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2020 | 476 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 941 | 0.030 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2020 | 510 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 15913 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 5214 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 9052 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 12035 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 5248 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 1247 | 0.020 |
Why?
|
| Humans | 7 | 2023 | 271967 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2008 | 105 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13398 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 165 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 31062 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12545 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 14647 | 0.020 |
Why?
|
| Middle Aged | 3 | 2023 | 90447 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 665 | 0.010 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2008 | 706 | 0.010 |
Why?
|
| Female | 4 | 2023 | 149251 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 2269 | 0.010 |
Why?
|
| Male | 3 | 2023 | 129048 | 0.010 |
Why?
|
| Aged | 2 | 2023 | 73494 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 1266 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 3981 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 39817 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6275 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 16630 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 7794 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 10260 | 0.010 |
Why?
|
| Animals | 1 | 2001 | 62782 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 4964 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 14003 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 81964 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 33911 | 0.000 |
Why?
|